116 results
Page 2 of 6
424B5
nqsibljdshsrnl
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
is5ammy60mj uxno8t
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
8-K
EX-99.1
6imr fv5acsy71s41y82
8 Jun 22
Results of Operations and Financial Condition
7:05am
8-K
EX-10.1
6y78 o5p95ky4qh
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am
PRE 14A
uzp7xrm
2 Aug 21
Preliminary proxy
4:31pm
8-K
EX-99.1
q9mqrh5nw8p6j05 e8
2 Aug 21
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
8:09am
8-K
EX-10.1
2q2 hsldip6ovpisff5
2 Aug 21
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
8:09am
8-K
EX-99.1
s0lgy0fu
1 Jun 21
Results of Operations and Financial Condition
7:36am